Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-06-25

Clinical Trial Update: Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis [Phase 1, Phase 2]

View source ↗

Summary

Early bactericidal activity data for multiple drugs (linezolid, gatifloxacin, levofloxacin, isoniazid, moxifloxacin) in HIV-negative adults with initial sputum …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gatifloxacin (Gatifloxacin)
  • ISONIAZID (ISONIAZID)
  • Levofloxacin (Levofloxacin)
  • Linezolid (Linezolid)
  • Moxifloxacin (moxifloxacin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Tuberculosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2009-06-25